J&J Challenges Risperdal Penalty As First Amendment Violation
This article was originally published in The Pink Sheet Daily
Executive Summary
In case that could impact use of state unfair trade practices statutes, Janssen seeks Supreme Court review of South Carolina’s $124 million judgment for Risperdal labeling and Dear Doctor letter.